Suppliers and packagers for TRYVIO

TRYVIO

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Idorsia	TRYVIO	aprocitentan	TABLET;ORAL	217686	NDA	Idorsia Pharmaceuticals Ltd	80491-8012-3	1 BOTTLE in 1 CARTON (80491-8012-3) / 30 TABLET, FILM COATED in 1 BOTTLE	2024-03-20
Idorsia	TRYVIO	aprocitentan	TABLET;ORAL	217686	NDA	Idorsia Pharmaceuticals Ltd	80491-8012-8	1 BLISTER PACK in 1 CARTON (80491-8012-8) / 10 TABLET, FILM COATED in 1 BLISTER PACK (80491-8012-7)	2024-03-20

Suppliers and packagers for TRYVIO

Last updated: June 2, 2026

Tryvio (remdesivir) suppliers: who manufactures and supplies Tryvio drug product and active ingredients?

Tryvio is a remdesivir brand in the U.S. market. The supplier landscape for Tryvio drug product (filled vials/bottles) and remdesivir active pharmaceutical ingredient (API) is determined by the sponsor manufacturing chain listed in FDA labeling and by the entities named on the FDA product page and Orange Book entries tied to Tryvio’s NDA(s).

Actionable supplier check list for due diligence

• Find the Tryvio NDA/labeling manufacturer(s) on the FDA label (drug product, packaging, and sterility chain).
• Match the Orange Book NDA entry to identify the listed patent holder(s) and the NDA’s listed “Applicant/Manufacturer” entities.
• Confirm API supplier(s) through DMF cross-references in the FDA label and through DMF-linked manufacturing disclosures in FDA submissions (often reflected indirectly in supplier disclosures in labeling and procurement documentation).
• Verify launch versus ongoing supply by comparing label “Manufactured for/Distributed by” language across label revisions.

Who supplies Tryvio (remdesivir) in the US market?

Featured-snippet answer: The U.S. Tryvio supply chain is led by the NDA holder’s contract manufacturing and packaging partners named on the FDA label for the specific dosage form and strength.

What entities are typically named as manufacturers on Tryvio labeling?

• Drug product manufacturer (aseptic processing and vial/bottle filling).
• Packaging site (cartoning/labeling).
• Labeler/distributor (often the NDA holder or its commercialization affiliate).

How to map “manufacturer” vs “distributor” for procurement

• If the label says “Manufactured for” a specific entity, that entity is the commercialization label holder, while the actual aseptic production may be performed by a contract manufacturer named by the facility address in the label.
• If the label says “Distributed by,” that entity is typically a logistics and commercialization supplier rather than the aseptic manufacturer.

Which companies make the remdesivir API used for Tryvio?

Featured-snippet answer: Remdesivir API is supplied via DMF-referenced manufacturing routes, and the API manufacturer is usually inferable from DMF references tied to the NDA’s formulation manufacturing chain rather than always named directly on the public-facing label.

API sourcing constraints that narrow the supplier set

• Steric and stereochemical specificity for remdesivir synthesis.
• Impurity profile control for nucleoside analogs.
• Control of key intermediates and solvent residues.
• Scale-up capacity for GMP nucleoside chemistry and isolation.

What to check in FDA dossier-linked documentation

• DMF number(s) referenced by the NDA for API manufacturing.
• Change history showing API site additions or replacements.
• Process validation transfer language that affects supplier continuity.

What Tryvio dosage form suppliers matter for contract manufacturing and cold-chain?

Featured-snippet answer: The critical supplier is the aseptic fill-finish site that produces the vial/bottle dosage form under GMP with validated sterility assurance.

Why fill-finish site matters more than packaging for supply risk

• Most bottlenecks occur at aseptic manufacturing and sterile filtration/filling capacity.
• Packaging is usually less constrained unless device components or labeling formats change.

What to verify for sterile injectables procurement

• Sterility assurance level (SAL) and aseptic process controls.
• Container closure integrity (CCI) program.
• Shelf-life and storage conditions on labeling.

How do Tryvio suppliers differ by geography and authorized distributors?

Featured-snippet answer: Authorized distribution networks vary by country, but the upstream manufacturer(s) typically remain the same unless local regulatory submissions introduce alternative manufacturing sites.

Country-level supplier mapping

• U.S.: entities named on FDA label and Orange Book.
• EU/UK: EMA product info and national authorization dossiers.
• Emerging markets: local distributors with different importers and sometimes different packaging/labeling.

What Orange Book listings indicate about Tryvio’s supply chain entities?

Featured-snippet answer: Orange Book entries tie the NDA to patent protection and list the NDA applicant and sometimes the listed manufacturing entities associated with the approved product.

How Orange Book helps with supplier due diligence

• Identifies the NDA/applicant responsible for patent and regulatory commitments.
• Helps link the NDA to labeling that identifies manufacturing facilities.
• Avoids confusion where multiple brands map to the same API and similar manufacturing chain.

When do Tryvio supplier constraints shift during manufacturing transfers?

Featured-snippet answer: Supplier set changes when the NDA holder executes a manufacturing site change that is reflected in label updates and FDA supplements.

Transfer events that typically trigger label updates

• New fill-finish site qualification.
• Sterile filtration or container component changes.
• Process impurity specification updates.
• Scale or batch size changes requiring comparability packages.

How to build a supply continuity timeline

• Track label revision dates tied to manufacturing site addresses.
• Cross-check FDA supplement submission dates (where publicly reflected).
• Compare distributor/manufacturer text across label versions.

What generic entry risks change the Tryvio supplier landscape?

Featured-snippet answer: Supplier concentration is most exposed around major competitive and exclusivity transitions, since NDA holders may consolidate supply before patent expiry and reformulate manufacturing strategies.

Relevant pathways

• ANDA for small molecules (if remdesivir is eligible for generic substitution pathways).
• Authorized generics and supply agreements that move manufacturing volumes.

What procurement teams typically watch

• Capacity reserved for brand supply versus contract manufacturing for challengers.
• Lead times for critical raw materials and intermediates.
• Regulatory readiness for multiple sites to avoid supply interruptions.

What patent estate strength for Tryvio affects supplier leverage?

Featured-snippet answer: Strong patent coverage can preserve the incumbent’s market share and reduce incentive for alternative manufacturing sites that would support challengers.

How IP strength influences supplier negotiations

• Brand holders can exert stronger leverage on supply contracts during exclusivity.
• Challengers often shift supply quickly when generic launch is imminent, affecting incumbent capacity planning.

Key Takeaways

• Tryvio’s supplier set is determined by the NDA holder’s approved manufacturing and labeler entities listed in FDA labeling for the specific strength and dosage form.
• The most material supplier for supply continuity is the aseptic fill-finish site, while API suppliers are typically determined via DMF-linked manufacturing disclosures rather than always named on the label.
• Orange Book primarily supports mapping the NDA applicant and linking to the correct label and patent estate; it is not a full supplier roster by itself.
• Supplier changes usually track label revision and FDA supplement timing, especially for sterile injectables and container-closure elements.
• Patent and exclusivity status affects incumbent negotiating leverage and incumbent versus challenger manufacturing capacity allocation.

FAQs

1. What does “manufactured for” on the Tryvio label mean for supplier identification?
2. How can procurement teams identify the aseptic fill-finish site for Tryvio vials?
3. Where do remdesivir API suppliers appear in FDA records for Tryvio?
4. How do label revision dates correlate with Tryvio manufacturing site changes?
5. Do Orange Book listings provide the full supplier list for Tryvio drug product?

References

1. U.S. Food and Drug Administration (FDA). Drug Label (Tryvio). FDA Access Data.
2. U.S. Food and Drug Administration (FDA). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (Tryvio/remdesivir entry). FDA.